Blood marker study for newborns with lack of oxygen at birth
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at a special blood marker in full-term newborns who had brain injury from lack of oxygen during birth. It aims to help doctors better understand and treat this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born at full term (at least 36 weeks of pregnancy).
- Your baby must have a diagnosis of hypoxic ischemic encephalopathy (brain injury from lack of oxygen).
- Your baby must be in stage I, II, or III of the condition based on the Sarnat system.
- Your baby must start cooling treatment (therapeutic hypothermia) within 6 hours of birth.
- You must give written permission for your baby to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for newborn babies who had an oxygen shortage around birth and now have severe brain injury. It aims to test approaches that may help improve outcomes after this kind of early-life brain damage.
This study looks at whether a computer can read a baby's brain-wave test (EEG) to help doctors predict outcomes after oxygen loss at birth. If it works, it could help guide treatment decisions.
This study uses whole genome sequencing to look at the genes of newborns with HIE (brain injury from lack of oxygen) who are receiving cooling treatment. The goal is to learn more about how genes may affect recovery and outcomes.
This early study tests whether giving melatonin to newborns with hypoxic-ischemic encephalopathy (brain injury from not enough oxygen around birth) can help protect the brain while they are cooled (therapeutic hypothermia). It may be most relevant if your baby shows early brain-injury signs and meets specific blood test and birth-history timing criteria.
This trial studies whether RLS-0071 is safe and can help some newborns with moderate or severe hypoxic-ischemic encephalopathy (HIE), a brain injury caused by low oxygen around birth. Babies in the study also receive standard whole-body cooling (therapeutic hypothermia), and the researchers will watch for side effects and early signs of benefit.
This study tests whether breathing a mix of hydrogen and oxygen gas can help protect the brain in babies who had a lack of oxygen around the time of birth (called HIE). It is looking for babies born full-term who need a breathing tube and are at high risk of brain damage.
Hear when a new Hypoxic-Ischemic Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.